Logo ofKesay Clinics Co.
Kesay Clinics Co. issued today, Jan. 22, the prospectus to float two million shares on the Nomu-Parallel Market. 
The offered shares represent 5.26% of its pre-IPO capital of SAR 38 million, divided into 38 million shares at a par value of SAR 1 per share. The shares account for 5% of post-IPO capital of almost SAR 40 million.
In December 2025, the the Capital Market Authority (CMA) approved the company’s Nomu listing application.
The IPO will be limited to qualified investors, as per the CMA instructions. The share offering will run for seven days from Feb. 11-22.
The company’s core business covers the provision of medical care services related to dermatology and cosmetic treatments, laser devices, and skin and hair care. According to its commercial register, the company’s activities also include integrated administrative services for offices and specialized medical complexes.
Company Profile
Company
Kesay Clinics Co.
Market
Nomu-Parallel Market
Core Activities
Medical care services
Pre-IPO Capital
SAR 38 mln
Number of Shares
38 mln
Post-IPO Capital
SAR 40 mln
New Number of Shares
40 mln
Nominal Value
SAR 1 per share
IPO Summary
Issue Percentage
5.26% of pre-IPO capital and 5% of post-IPO capital
Offered Shares
2 mln
IPO Minimum Limit
10 shares
IPO Maximum Limit
1,999,990 shares
Offer Period
Feb. 11-22, 2026
Final Allocation
Feb. 25, 2026
Surplus Refund (if any)
March 2, 2026
Additional Information
Financial Advisor
Estidamah Capital
Lead Manager
Derayah Financial
Receiving Agents
Alinma Capital, Al Rajhi Capital, SNB Capital, BSF Capital, Riyad Capital, ANB Capital, Albilad Capital, AlJazira Capital, Alistithmar Capital, Yaqeen Capital, Alkhabeer Capital, SAB Invest, Sahm Capital, GIB Capital, Musharaka Capital, EFG-Hermes, Awaed Alosool Capital and Dinar Investment.
Logo ofKesay Clinics Co.
Kesay Clinics Co. issued today, Jan. 22, the prospectus to float two million shares on the Nomu-Parallel Market.
The offered shares represent 5.26% of its pre-IPO capital of SAR 38 million, divided into 38 million shares at a par value of SAR 1 per share. The shares account for 5% of post-IPO capital of almost SAR 40 million.
In December 2025, the the Capital Market Authority (CMA) approved the company’s Nomu listing application.
The IPO will be limited to qualified investors, as per the CMA instructions. The share offering will run for seven days from Feb. 11-22.
The company’s core business covers the provision of medical care services related to dermatology and cosmetic treatments, laser devices, and skin and hair care. According to its commercial register, the company’s activities also include integrated administrative services for offices and specialized medical complexes.
Company Profile
Company
Kesay Clinics Co.
Market
Nomu-Parallel Market
Core Activities
Medical care services
Pre-IPO Capital
SAR 38 mln
Number of Shares
38 mln
Post-IPO Capital
SAR 40 mln
New Number of Shares
40 mln
Nominal Value
SAR 1 per share
IPO Summary
Issue Percentage
5.26% of pre-IPO capital and 5% of post-IPO capital
Offered Shares
2 mln
IPO Minimum Limit
10 shares
IPO Maximum Limit
1,999,990 shares
Offer Period
Feb. 11-22, 2026
Final Allocation
Feb. 25, 2026
Surplus Refund (if any)
March 2, 2026
Additional Information
Financial Advisor
Estidamah Capital
Lead Manager
Derayah Financial
Receiving Agents
Alinma Capital, Al Rajhi Capital, SNB Capital, BSF Capital, Riyad Capital, ANB Capital, Albilad Capital, AlJazira Capital, Alistithmar Capital, Yaqeen Capital, Alkhabeer Capital, SAB Invest, Sahm Capital, GIB Capital, Musharaka Capital, EFG-Hermes, Awaed Alosool Capital and Dinar Investment.
